ImetelChat

I have to add ~ the Compassionate Use for Imetelstat *was* online. I saw it, it was an official site, and it was there. Then it was down. Follow me here ~ for Imet to wind up available for Compassionate Use, even for a micro-second, it would have to pass through Doctors / Experts / Clinicians involv...

Totally understand - take some time and enjoy some fresh autumn air. My point on ASH is if this clinical data is not strong, we won't see it at ASH. If either of these abstracts are accepted by ASH, then there is developments of merit in these trials. And I just don't believe Janssen would even subm...

Hello BP, I feel inclined to reply to your post, and the reply, in support. And dovetail on a point you made.... (ps - it's towards the end and ends with Period.) I'll refrain from 'forward looking + statements', however I am compelled to agree with your points. You are correct that these trials are...

Yes, finally after all these years, this could be the week we have a(n initial culmination). And if not this week, only a week or two more. So in the sands of time of Geron, this is a heartbeat away. And if all goes as expected, with a Continuation from Janssen followed by an opt-in from GERN, the n...

No cards shown - although I think he is tipping his hand with the second 'derisk' statement and confidence in either decision from Janssen.

(the Decision is yes.)

I agree with all the points. It is a foregone conclusion that Janssen will Continue and Geron now has the funds to confidently opt-in - ET which showed near 100% remission - Mayo Pilot studies as peer reviewed in NEJM, 'tantamount to a cure' in some cases as stated in Mayo Clinic brochures - MF tria...

Hello again, I believe this filing is identical (up to $250 M) as the one last month except they amended to include (or grant shares or something) to the investment firm handling the potential sale. So I could be wrong but I don't think this is anything new but an amendment to what we have seen. How...

Thank you, Biopearl, for posting and maintaining the site. This is a fantastic pre-clinical. I'm playing in my head to try to decide which pre-clinical has bigger implications, the AML combo published at ASH 2016 or this one. I'm thinking AML combo has more immediate impact, however in the long (and...

My sincere condolences.

His passion was clear, and he never let on to his personal battles.

A very sad day, and I wish Imet therapy could have come to fruition for him to see...

Finally was able to log back in, yes! (Never can log in on my phone for some reason). Anyways, here is a summary I just wrote on Yahoo!, which will be buried / deleted, but not before 'Wayne' most likely calls me a Communist and a racist among other things... Around 5 years after the Mayo Clinic pil...

Per presentation - As of August 2017, OS has not been achieved in MF test groups. It is interesting to note that during ASH 2016, Janssen presented the database of information that they had spent the time & resources to compile: Abstract #4769 Characterization of disease, treatment patterns, and out...

A potential date to look forward to.... as we certainly should be expecting to have data submitted... http://www.hematology.org/Annual-Meeting/Abstracts/2853.aspx Acceptance/Rejection Notification Notification regarding acceptance or rejection of abstracts will be sent to the presenting author in ea...

Hi All, Excited to have received a login to join the board, and even more excited about the prospects of Imetelstat. The light certainly has been turned on at the end of the tunnel, and there is not reason to think there are any roadblocks in the tunnel.... I truly believe that Janssen has been maki...